Radcliffe Group Events
Our goal is to identify and amplify ideas that transform patient outcomes. To that end, we curate, stage and broadcast a range of events that bring our community together, sharing insights with a global audience, and accelerating professional development throughout the cardiovascular field.
Transcatheter Interventions Online (TIO)
TIO is a live virtual event dedicated t transcatheter treatment strategies for coronary and structural heart disease. It connects thousands of healthcare professionals with leading clinicians, opinion-formers and research teams for discussion, live cases, presentations, breakout sessions and symposia.
Rhythm Interventions Online (RIO)
A 3-day broadcast event, RIO brings together experts from around the world to explore the latest electrophysiology treatment strategies in ablation and arrhythmias. As with all our Radcliffe events, delegates enjoy free access to CME-accredited learning, insight and live cases from global centres of excellence.
Vascular Interventions Online (VIO)
Discover the latest vascular treatment strategies at this innovative event. Spanning three days, with a dedicated focus for each day across Aortic, Venous and Peripheral Arterial Disease / Lower Limb, VIO delivers best-in-class practical learning and cutting-edge live cases to support the educational needs of the global vascular community.
Advancements in Obesity Management (AOM)
Radcliffe Cardiology is proud to announce a new one-day event, Advancements in Obesity Management (AOM). Explore the intricate links between obesity and cardiovascular disease, gaining key insights in evolving diagnostic and treatment strategies.
Transcatheter Interventions Online – Mechanical Circulatory Support (TIO MCS)
Radcliffe Cardiology is proud to announce the expansion of its Transcatheter Interventions Online event series with a focused edition on Mechanical Circulatory Support. Transcatheter Interventions Online – Mechanical Circulatory Support (TIO MCS), is a new half-day virtual conference dedicated to advancing knowledge and outcomes in this dynamic field.
New Horizons in Amyloidosis (NHA)
Radcliffe Cardiology is proud to announce a new one-day event New Horizons in Amyloidosis (NHA), specially focused on providing an update on the diagnosis and treatment of cardiac amyloidosis and its sequelae in recognition of this rapidly developing field.